- Home
- XBIO vs OTRK Comparison
XBIO vs OTRK Comparison
Compare XBIO & OTRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- OTRK
- Stock Information
- Founded
- XBIO N/A
- OTRK 2003
- Country
- XBIO United States
- OTRK United States
- Employees
- XBIO N/A
- OTRK N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- OTRK Misc Health and Biotechnology Services
- Sector
- XBIO Health Care
- OTRK Health Care
- Exchange
- XBIO Nasdaq
- OTRK Nasdaq
- Market Cap
- XBIO 6.3M
- OTRK 7.1M
- IPO Year
- XBIO N/A
- OTRK N/A
- Fundamental
- Price
- XBIO $4.03
- OTRK $1.59
- Analyst Decision
- XBIO Hold
- OTRK Strong Buy
- Analyst Count
- XBIO 1
- OTRK 1
- Target Price
- XBIO N/A
- OTRK $45.00
- AVG Volume (30 Days)
- XBIO 4.8K
- OTRK 26.7K
- Earning Date
- XBIO 03-20-2025
- OTRK 04-15-2025
- Dividend Yield
- XBIO N/A
- OTRK N/A
- EPS Growth
- XBIO N/A
- OTRK N/A
- EPS
- XBIO N/A
- OTRK N/A
- Revenue
- XBIO $2,523,427.00
- OTRK $11,239,000.00
- Revenue This Year
- XBIO N/A
- OTRK N/A
- Revenue Next Year
- XBIO N/A
- OTRK $48.09
- P/E Ratio
- XBIO N/A
- OTRK N/A
- Revenue Growth
- XBIO 7.15
- OTRK N/A
- 52 Week Low
- XBIO $2.78
- OTRK $1.36
- 52 Week High
- XBIO $5.20
- OTRK $16.05
- Technical
- Relative Strength Index (RSI)
- XBIO 45.61
- OTRK 46.88
- Support Level
- XBIO $3.91
- OTRK $1.36
- Resistance Level
- XBIO $4.24
- OTRK $1.72
- Average True Range (ATR)
- XBIO 0.17
- OTRK 0.10
- MACD
- XBIO -0.01
- OTRK 0.00
- Stochastic Oscillator
- XBIO 28.93
- OTRK 59.49
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About OTRK Ontrak Inc.
Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The Company's technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized care program. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.